Multiple Sclerosis Registry Study
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study creates a registry for people with multiple sclerosis (MS) to track their health over time. The information gathered may help researchers better understand MS and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple sclerosis (MS).
- You can speak and understand English comfortably.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry (a voluntary database) for people diagnosed with multiple sclerosis or a related first episode called clinically isolated syndrome. It helps researchers learn about how these conditions affect people over time.
This study follows people with multiple sclerosis over time to learn more about the disease and improve care. If you join, you will help researchers understand MS better, which could lead to better treatments.
This study builds a patient-powered research network for people living with multiple sclerosis. It may help by gathering real-world information from patients to improve understanding of the disease over time.
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
This study is a registry that collects information from people who have multiple sclerosis (MS). It helps researchers better understand MS in the Lorraine region and may guide future care.
This registry enrolls people with a confirmed diagnosis of multiple sclerosis (MS) who are age 18 or older and live in Switzerland (or receive their MS care there). It helps researchers better understand MS in the Swiss population and may improve future studies and care.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.